Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan

The objectives of this study are to assess the efficacy and safety of frovatriptan, and rizatriptan in the subgroup of women with menstrually related migraine of a multicenter, randomized, double blind, cross-over study. Each patient received frovatriptan 2.5 mg or rizatriptan 10 mg in a randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Savi, Lidia, Omboni, Stefano, Lisotto, Carlo, Zanchin, Giorgio, Ferrari, Michel D., Zava, Dario, Pinessi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2011
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208043/
https://www.ncbi.nlm.nih.gov/pubmed/21842274
http://dx.doi.org/10.1007/s10194-011-0366-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3208043/
https://www.ncbi.nlm.nih.gov/pubmed/21842274
http://dx.doi.org/10.1007/s10194-011-0366-9

Ejemplares similares